IL10 and non-small cell lung carcinoma: NSCLC-derived DCs demonstrate increased secretion of IL-10 and higher expression of B7-H3 T cell co-inhibitory molecules compared with their counterparts in normal lungs, creating an immunosuppressive TME where anti-tumor T cells fail to become effectively activated (Schneider et al., 2011).